P01.035  Nivolumab and Temozolomide (TMZ) vs TMZ alone in newly diagnosed elderly patients (pts) with Glioblastoma (GBM) (NUTMEG): Trial in progress

Khasraw, Mustafa; McDonald, K; Yip, S; Verhaak, R G; Heimberger, A B; Hall, M; Barnes, E; Hovey, E; Ellingson, B M; Lwin, Z

File(s) not publicly available

P01.035 Nivolumab and Temozolomide (TMZ) vs TMZ alone in newly diagnosed elderly patients (pts) with Glioblastoma (GBM) (NUTMEG): Trial in progress

journal contribution

posted on 2018-09-19, 00:00 authored by Mustafa Khasraw, K McDonald, S Yip, R G Verhaak, A B Heimberger, M Hall, E Barnes, E Hovey, B M Ellingson, Z Lwin

P01.035 Nivolumab and Temozolomide (TMZ) vs TMZ alone in newly diagnosed elderly patients (pts) with Glioblastoma (GBM) (NUTMEG): Trial in progress

History

Journal

Neuro-Oncology

Volume

20

Issue

suppl_3

Pagination

iii236 - iii236

Publisher

Oxford University Press (OUP)

Publisher DOI

https://doi.org/10.1093/neuonc/noy139.077

ISSN

1522-8517

eISSN

1523-5866

Language

en

Publication classification

E3 Extract of paper

Usage metrics

Keywords

Untagged

File(s) not publicly available

P01.035 Nivolumab and Temozolomide (TMZ) vs TMZ alone in newly diagnosed elderly patients (pts) with Glioblastoma (GBM) (NUTMEG): Trial in progress

History

Journal

Volume

Issue

Pagination

Publisher

Publisher DOI

ISSN

eISSN

Language

Publication classification

Usage metrics

Categories

Keywords

Licence

Exports